Latent tuberculosis screening for inflammatory bowel disease in tuberculosis endemic region remains porous and suboptimal: A multicentre study

doi:10.3748/wjg.v32.i4.114897

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 4

This Article

(44)

(96)

(0)

(20)

(1506)

(1)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Cohort Study

World J Gastroenterol. Jan 28, 2026; 32(4): 114897
Published online Jan 28, 2026. doi: 10.3748/wjg.v32.i4.114897

Table 2 Audit of screening before advanced therapy, n (%)

Latent TB screening¹	n = 378
TST	261 (69.04)
IGRA	298 (78.83)
QuantiFERON Gold	295
TSPOT²	7
CXR	300 (79. 36)
CT chest (HRCT/CECT chest)	242 (64.02)
Standard screening³	77/131 (58.77)
Incomplete screening³	54/131 (41.22)
Immunodiagnostic predominant
Both	208 (55.02)
Either	353 (93.38)
Neither	25 (6.61)
Diligent screening	125 (33.06)
Limited screening	253 (66.93)
Patents on advanced therapy > 1 year	184 (48.67)
Annual screening of patients with advanced therapy > 1 year	50/184 (27.17)

¹Five patients no screening done.

²Four patients underwent both tests.

³Excluding all patients undergoing computed tomography chest.

TB: Tuberculosis; TST: Tuberculin skin test; IGRA: Interferon-gamma release assay; CXR: Chest X-ray; CT: Computed tomography; HRCT: High-resolution computed tomography; CECT: Contrast-enhanced computed tomography.

Full Size Table

Citation: Jha DK, Prasad S, Valsan A, Mishra S, Nair P, Koshy AK, Singh S, Prasad AS, Shukla R, Ahamed R, Augustine P, Natarajan K, Peddi K, Kulkarni A, Bhatia S, Pachisia AV, Singh PK, Jena A, Gupta S, Jain S, Padmaprakash K, Kakadiya R, Kumar A, Shukla S, Dutta U, Hande V, Thareja S, Sharma V. Latent tuberculosis screening for inflammatory bowel disease in tuberculosis endemic region remains porous and suboptimal: A multicentre study. World J Gastroenterol 2026; 32(4): 114897
URL: https://www.wjgnet.com/1007-9327/full/v32/i4/114897.htm
DOI: https://dx.doi.org/10.3748/wjg.v32.i4.114897

Jha DK, Prasad S, Valsan A, Mishra S, Nair P, Koshy AK, Singh S, Prasad AS, Shukla R, Ahamed R, Augustine P, Natarajan K, Peddi K, Kulkarni A, Bhatia S, Pachisia AV, Singh PK, Jena A, Gupta S, Jain S, Padmaprakash K, Kakadiya R, Kumar A, Shukla S, Dutta U, Hande V, Thareja S, Sharma V. Latent tuberculosis screening for inflammatory bowel disease in tuberculosis endemic region remains porous and suboptimal: A multicentre study. World J Gastroenterol 2026; 32(4): 114897 [PMID: 41640875 DOI: 10.3748/wjg.v32.i4.114897]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.